DraftKings Earnings and Guidance Weigh on Shares

DraftKings earnings showed strong revenue and EBITDA growth but conservative fiscal guidance spurred a steep share decline and tightened trader positioning.

February 14, 2026·2 min read
View all news articles
Flat filled vector of a sportsbook vault dimming to symbolize DraftKings earnings and conservative guidance pressing shares.

KEY TAKEAWAYS

  • Q4 revenue rose 43% to $2.0B and adjusted EBITDA was $343M.
  • FY 2026 guidance set revenue at $6.5-$6.9B and adjusted EBITDA at $700-$900M.
  • Shares closed down about 13.5% following the conservative guidance.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

DraftKings Inc. (DKNG) reported strong revenue growth and higher adjusted EBITDA for Q4 2025 on Feb. 12, 2026, but its conservative guidance for fiscal 2026 sent shares sharply lower the following day.

Quarter Results and Profitability

DraftKings posted Q4 2025 revenue of $2.0 billion, up 43% from $1.4 billion a year earlier. Adjusted EBITDA rose to $343 million from $89 million, reflecting improved profitability. Net income turned positive at $136 million, compared with a loss of about $135 million in Q4 2024.

Average revenue per monthly unique payer increased to $139 from $97, signaling stronger monetization. Monthly unique payers totaled 4.8 million, essentially flat year over year and up 5% excluding Jackpocket. For the full year 2025, the company reported revenue of $6.1 billion, adjusted EBITDA of $620 million, and net income of roughly $4 million.

Guidance, Cash Position, and Market Reaction

DraftKings forecasted fiscal 2026 revenue between $6.5 billion and $6.9 billion, with adjusted EBITDA of $700 million to $900 million. This outlook assumes investments in the DraftKings Predictions product, expansion into new jurisdictions, and broader market growth.

The company ended 2025 with $1.1 billion in cash and cash equivalents, up from $788 million at the end of 2024. It repurchased 16 million shares during the year.

Sports betting was live in 26 states plus the District of Columbia, covering about 52% of the U.S. population. iGaming operated in five states, and Ontario's sports betting covered roughly 40% of that province’s population.

Shares closed down about 13.5% at the market close on Feb. 13, 2026, as investors weighed the cautious 2026 targets against the quarter’s gains. Management will provide further detail at a virtual Investor Day on March 2, 2026.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Read other top news stories

OpenAI Employee Arrested Over Hidden Recording Device

OpenAI Employee Arrested Over Hidden Recording Device

OpenAI employee arrested after a hidden device was discovered; company says models identified installer and found no data loss easing investor risk.

Cipher Digital Convertible Notes Proposal Sends Shares Lower

Cipher Digital Convertible Notes Proposal Sends Shares Lower

Cipher Digital convertible notes proposal would raise $850 million and include a concurrent exchange, raising dilution concerns and pressuring shares.

Character.AI Bankruptcy Draws Disney Interest

Character.AI Bankruptcy Draws Disney Interest

Character.AI bankruptcy starts a Section 363 sale with Disney as stalking-horse and $20 million bid, compressing the auction and shaping recoveries.

AST SpaceMobile Downgrade Sparks Concern

AST SpaceMobile Downgrade Sparks Concern

AST SpaceMobile downgrade after Piper Sandler cut its target, citing launch pace doubts and SpaceX competition, tightening trader positioning.

Six Flags Over Georgia Incident Prompts Ride Closures

Six Flags Over Georgia Incident Prompts Ride Closures

Six Flags Over Georgia incident triggered precautionary coaster closures and state reviews, raising near-term operational risk to attendance and shares.

Johnson & Johnson Q3 2026 Earnings Rise, MedTech Lags

Johnson & Johnson Q3 2026 Earnings Rise, MedTech Lags

Johnson & Johnson Q3 2026 earnings raised guidance to a $101.2 billion sales midpoint while MedTech weakness may force traders to reprice device risk.